InvestSMART

Memphasys Limited (ASX: MEM) - Announcements

- Current share price for MEM : $0.005

ASX company news and announcements for Memphasys Limited (MEM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Memphasys Limited (MEM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Memphasys Limited (MEM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Memphasys Limited (MEM)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$15 Notification regarding unquoted securities - MEM 3 Jun 2024 10:06AM $0.008 $0.005 fallen by 37.50%
$15 Industry experts to expedite animal breeding products 30 May 2024 8:20AM $0.008 $0.005 fallen by 37.50%
$15 Investor Presentation 21 May 2024 4:32PM $0.009 $0.005 fallen by 44.44%
$15 Felix Japanese trial provides sperm preparation benefits 20 May 2024 10:13AM $0.008 $0.005 fallen by 37.50%
$15 Investor webinar invitation 20 May 2024 8:27AM $0.008 $0.005 fallen by 37.50%
$15 2024 Investor Presentation 9 May 2024 3:18PM $0.008 $0.005 fallen by 37.50%
$15 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2024 3:46PM $0.009 $0.005 fallen by 44.44%
$15 EGM update and advance of funds 18 Mar 2024 10:48AM $0.011 $0.005 fallen by 54.55%
$15 Felix TM System Sales Orders Accelerate in Japan 18 Mar 2024 8:26AM $0.011 $0.005 fallen by 54.55%
$15 Initial Director's Interest Notice MA 14 Mar 2024 8:22AM $0.011 $0.005 fallen by 54.55%
$15 Director Appointment - Michael Atkins 14 Mar 2024 8:22AM $0.011 $0.005 fallen by 54.55%
$15 Half Yearly Report and Accounts 26 Feb 2024 5:51PM $0.010 $0.005 fallen by 50%
$15 s708A cleansing statement 20 Feb 2024 1:49PM $0.009 $0.005 fallen by 44.44%
$15 Notification regarding unquoted securities - MEM 19 Feb 2024 1:51PM $0.009 $0.005 fallen by 44.44%
$15 Notification regarding unquoted securities - MEM 19 Feb 2024 1:49PM $0.009 $0.005 fallen by 44.44%
$15 Application for quotation of securities - MEM 19 Feb 2024 1:45PM $0.009 $0.005 fallen by 44.44%
$15 Results of General Meeting 15 Feb 2024 8:11AM $0.009 $0.005 fallen by 44.44%
$15 Quarterly Activities/Appendix 4C Cash Flow Report 25 Jan 2024 9:29AM $0.014 $0.005 fallen by 64.29%
$15 AI-Port Update - Spring Field Trial Yields Positive Results 25 Jan 2024 9:21AM $0.014 $0.005 fallen by 64.29%
$15 Change of venue for General Meeting of shareholders 19 Jan 2024 5:12PM $0.013 $0.005 fallen by 61.54%
$15 Top 20 securityholders 18 Jan 2024 10:58AM $0.012 $0.005 fallen by 58.33%
$15 Rights issue entitlement offer completion 18 Jan 2024 10:54AM $0.012 $0.005 fallen by 58.33%
$15 Appendix 3G rights issue entitlement options 18 Jan 2024 10:53AM $0.012 $0.005 fallen by 58.33%
$15 Appendix 2A rights issue entitlement 18 Jan 2024 10:53AM $0.012 $0.005 fallen by 58.33%
$15 Appendix 3B - Extension of Settlement Date 17 Jan 2024 2:03PM $0.013 $0.005 fallen by 61.54%

226 - 250 of 645 results

Page 10 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.